Literature DB >> 28927763

Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.

Anna G Sorace, Sara Harvey, Anum Syed, Thomas E Yankeelov.   

Abstract

OBJECTIVE: To discuss standard-of-care and emerging imaging techniques employed for screening and detection, diagnosis and staging, monitoring response to therapy, and guiding cancer treatments. DATA SOURCES: Published journal articles indexed in the National Library of Medicine database and relevant websites.
CONCLUSION: Imaging plays a fundamental role in the care of cancer patients and specifically, breast cancer patients in the neoadjuvant setting, providing an excellent opportunity for interprofessional collaboration between oncologists, researchers, radiologists, and oncology nurses. Quantitative imaging strategies to assess cellular, molecular, and vascular characteristics within the tumor is needed to better evaluate initial diagnosis and treatment response. IMPLICATIONS FOR NURSING PRACTICE: Nurses caring for patients in all settings must continue to seek education on emerging imaging techniques. Oncology nurses provide education about the test, ensure the patient has appropriate pre-testing instructions, and manage patient expectations about timing of results availability.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRI; PET; interprofessional collaborations; optical imaging; quantitative imaging; ultrasound

Mesh:

Year:  2017        PMID: 28927763      PMCID: PMC5667646          DOI: 10.1016/j.soncn.2017.08.008

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  115 in total

1.  Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis.

Authors:  Yuting Wang; Chengpeng Zhang; Jianjun Liu; Gang Huang
Journal:  Breast Cancer Res Treat       Date:  2011-09-30       Impact factor: 4.872

2.  Three-dimensional contrast-enhanced sonography in the assessment of breast tumor angiogenesis: correlation with microvessel density and vascular endothelial growth factor expression.

Authors:  Man Chen; Wen-ping Wang; Wan-ru Jia; Lei Tang; Yi Wang; Wei-wei Zhan; Xiao-chun Fei
Journal:  J Ultrasound Med       Date:  2014-05       Impact factor: 2.153

3.  Quantitative ultrasound in cancer imaging.

Authors:  Ernest J Feleppa; Jonathan Mamou; Christopher R Porter; Junji Machi
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

Review 4.  Neoadjuvant chemotherapy--monitoring: clinical examination, ultrasound, mammography, MRI, elastography: only one, only few or all?

Authors:  Rüdiger Schulz-Wendtland
Journal:  Eur J Radiol       Date:  2012-09       Impact factor: 3.528

5.  Correlating sonography, mammography, and pathology in the assessment of breast cancer size.

Authors:  T J Hieken; J Harrison; J Herreros; J M Velasco
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

6.  Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.

Authors:  Sang Hee Park; Woo Kyung Moon; Nariya Cho; In Chan Song; Jung Min Chang; In-Ae Park; Wonshik Han; Dong-Young Noh
Journal:  Radiology       Date:  2010-10       Impact factor: 11.105

Review 7.  Performance of FDG PET/CT in the clinical management of breast cancer.

Authors:  David Groheux; Marc Espié; Sylvie Giacchetti; Elif Hindié
Journal:  Radiology       Date:  2012-12-06       Impact factor: 11.105

8.  Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

Authors:  Joseph G Rajendran; David A Mankoff; Finbarr O'Sullivan; Lanell M Peterson; David L Schwartz; Ernest U Conrad; Alexander M Spence; Mark Muzi; D Greg Farwell; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

9.  Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.

Authors:  Albert Cerussi; David Hsiang; Natasha Shah; Rita Mehta; Amanda Durkin; John Butler; Bruce J Tromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

Review 10.  Relevance of Pathological Complete Response after Neoadjuvant Therapy for Breast Cancer.

Authors:  Angela Pennisi; Thomas Kieber-Emmons; Issam Makhoul; Laura Hutchins
Journal:  Breast Cancer (Auckl)       Date:  2016-07-25
View more
  2 in total

1.  Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer.

Authors:  L Corke; L Luzhna; K Willemsma; C Illmann; M Mcdermott; C Wilson; C Simmons; N LeVasseur
Journal:  Breast Cancer Res Treat       Date:  2022-06-15       Impact factor: 4.624

2.  Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting.

Authors:  John Virostko; Anna G Sorace; Kalina P Slavkova; Anum S Kazerouni; Angela M Jarrett; Julie C DiCarlo; Stefanie Woodard; Sarah Avery; Boone Goodgame; Debra Patt; Thomas E Yankeelov
Journal:  Breast Cancer Res       Date:  2021-11-27       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.